Titus H.J. Huisman
Hemoglobinopathy Laboratory
Patient Information:
Sickle Cell Information Center
Sickle
Cell Disease
Use of Hydroxyurea
About
Augusta, Georgia
Includes links to maps,
driving directions and
local attractions
History of the Sickle Cell Center
Current Research
The
Sickle Cell Center at the Medical College of Georgia has been involved in
research projects dealing with various aspects of sickle cell disease since
its inception. It is the home for STOP
I & II which are led by Dr. Robert J. Adams,
Regent’s Professor of Neurology at MCG. This multi-center study conducted
in the US and Canada showed that transfusions can prevent first-time stroke
in children with sickle cell disease who are identified to be at high risk
with TCD (Transcranial Doppler). The STOP II study,started July 1,
2000, and is investigating the duration of transfusion required to minimize
the risk in children with high TCD. The Hemoglobinopathy Laboratory also
serves as the Core Laboratory for the Multi-Center STOP and STOP II studies.
Copyright
Medical College of Georgia
All rights reserved.
Centers and
Institutes | Medical College of Georgia
Department of Medicine | Section
of Hematology/Oncology
Please email comments, suggestions or questions to:
Betsy Clair, bclair@mail.mcg.edu
December 07, 2005